April 11, 2016: Laboratory Markets has today published its most comprehensive market study of DNA and RNA sequencing. This study involved the participation of 526 experienced end-users and profiled current practices, developments, trends and plans over the next three years, as well as growth and opportunities across key sectors of these markets. Its findings provide a wealth of market information on the current and evolving laboratory use of nucleotide sequencing methods.

 

  • Current and 3-year market estimates provided by experienced end-users
  • Recent growth in sequencing and estimated growth over the next 3 years (±% change)
  • Sequencing laboratory locations and preferred external laboratories
  • Sequencing techniques used currently and anticipated in 3 years (±% change)
  • Sequencing instruments used currently and anticipated in 3 years (±% change)
  • Current sequencing suppliers and anticipated suppliers in 3 years (±% change)
  • Current sequencing applications and anticipated applications in 3 years (±% change)
  • Clonal amplification methods
  • Read lengths, accuracy, reads per run, time per run and sequencing costs
  • Disease areas relating to sequencing now and in 3 years (±% change)
  • Nucleotide types currently sequenced and anticipated in 3 years (±% change)
  • Software used by sequencers
  • Costs of sequencing per sample and associated nucleotide lengths
  • Numbers of samples sequenced per month
  • Disease biomarkers investigated using sequencing
  • Biomarker disease areas and molecular types
  • Sample preparation methods used in sequencing
  • Purpose, fields or sectors
  • Global regions, countries and organisation types

 

Data File


In addition to the PDF report, purchasers of the report and data package receive the full raw data collected during the conduct of this global study in Excel format allowing the in-depth analysis of specific market sectors or segments of interest, as well as looking at relationships between different areas of the market. This raw data can be analysed in many ways, including the identification of new market opportunities. For example, it is possible to analyse areas of the DNA and RNA sequencing market where the highest rates of growth are expected by end-users; relationships between techniques and applications, costs and throughput, as well as by suppliers into specific areas of the market. Data can also be analysed by country, region and in many other ways. Organisation names corresponding to each of the study participants are also provided, for instant sales and marketing opportunities.

The last decade has seen remarkable innovation and development in the nucleotide sequencing field. Today, a number of powerful high–throughput sequencing technologies are available and are being used to address an increasingly diverse range of biological problems. The quantitative scale and efficiencies of next-generation sequencing platforms are also seeing unprecedented progress and growth in many areas of fundamental research. Dramatic reductions in the associated costs and the operational complexities of these techniques are opening up applications in areas that would have been unimaginable just a decade ago. 

This report presents the findings of a new global market study of nucleotide sequencing, which profiled the use of these techniques from the end-users' perspective. This study, which evaluated end-users' current sequencing practices and three-year plans investigated:

  • Market growth
  • Competitive positions of global sequencing suppliers
  • Sequencing laboratory location
  • Preferred external Laboratories
  • Sequencing methods
  • Sequencing laboratory instruments
  • Company suppliers
  • Applications
  • Clonal amplification
  • Diseases
  • Nucleotide types
  • Software
  • Sequencing performance
  • Numbers of samples
  • Disease biomarkers
  • Study samples
  • Sample preparation
  • Advantages and disadvantages
  • Fields
  • Participant roles
  • Organisation type
  • Experience
  • Countries and regions